Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Gufic BioSciences Ltd

NSE: GUFICBIO · BSE: 509079 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹423.75
Market cap: ₹4,249 Cr
Revenue (annual): ₹944.0 Cr
Net profit (annual): ₹64.21 Cr
P/E (TTM): 57.9×Sector 50.4×
Promoter holding: 72.50%+0.00% QoQ
FII holding: 0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 2 Management Change 1 Legal & Regulatory 1 Credit Rating 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 19:35 IST BSE

Financial Results

Gufic BioSciences Q1 FY27 Results: Net Profit ₹22.3 Cr, Up 70.2% YoY

Gufic BioSciences Ltd reported revenue from operations of ₹260.8 Cr (+16.6% YoY) and net profit of ₹22.3 Cr (+70.2% YoY) for Q1 FY27.

Key figure: Net profit ₹22.3 Cr · +70.2% YoY

Open full results → Read the filing ↗

29 May 2026 22:13 IST BSE

Financial ResultsAlfa Alert

Gufic BioSciences Q4 FY26 Results: Net Profit ₹21.9 Cr, Up 184.4% YoY

Gufic BioSciences Ltd reported revenue from operations of ₹251.8 Cr (+22.8% YoY) and net profit of ₹21.9 Cr (+184.4% YoY) for Q4 FY26.

Key figure: Net profit ₹21.9 Cr · +184.4% YoY

Open full results → Read the filing ↗